AXIM BIOTECHNOLOGIES, INC. Amortization of Deferred Charges
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Amortization of Deferred Charges of $210.09 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredCharges · last filed 2023-04-17
- AXIM BIOTECHNOLOGIES, INC. amortization of deferred charges for fiscal 2022 was $210.09K, a 44.26% decline from fiscal 2021.
- AXIM BIOTECHNOLOGIES, INC. amortization of deferred charges for fiscal 2021 was $376.94K.
| Period end | Amortization of Deferred Charges 12 month |
|---|---|
| 2022-12-31 | $210.09K 10-K · filed 2023-04-17 |
| 2021-12-31 | $376.94K 10-K · filed 2023-04-17 |